Target intelligence / Profile preview

Klotho-Forkhead box protein O1 signaling pathway (KL-FOXO1 pathway)

Target
KL-FOXO1 pathway
Molecular classification
Transcription factor (FOXO1), Glycosidase (Klotho), Transmembrane protein (Klotho), Hormone (Soluble Klotho)
01

Overview

The FOXO1/KLOTHO pathway, often referred to as the Klotho-FOXO1 signaling axis, is a key molecular mechanism that integrates systemic metabolism with cellular stress resistance and longevity. Klotho is a transmembrane protein primarily expressed in the kidneys that acts as an aging suppressor; it can be shed into the circulation as a soluble hormone. In this pathway, Klotho inhibits the insulin and insulin-like growth factor-1 (IGF-1) signaling cascades, which typically activate the PI3K/AKT pathway. Because AKT normally phosphorylates and inactivates the transcription factor FOXO1 by sequestering it in the cytoplasm, Klotho-mediated inhibition of AKT allows FOXO1 to translocate into the nucleus. Once in the nucleus, FOXO1 drives the transcription of essential antioxidant enzymes, such as manganese superoxide dismutase (MnSOD), which neutralize reactive oxygen species and protect cells from oxidative damage. Disruption of the FOXO1/KLOTHO axis is closely linked to age-related pathologies, including chronic kidney disease, cardiovascular dysfunction, and neurodegeneration. In many disease states, Klotho levels decline, leading to increased oxidative stress and impaired FOXO1-mediated cellular protection. Therapeutic interventions aimed at this pathway include the use of recombinant Klotho protein or drugs like SGLT2 inhibitors and Vitamin D analogs that enhance endogenous Klotho expression. Such strategies are being explored to treat metabolic syndrome and slow the progression of chronic renal and vascular diseases.

Other names
Klotho-FOXO1 axisKlotho-mediated FOXO1 activationKL-FOXO1 signaling axisKlotho/FOXO signaling pathwayα-Klotho-FOXO1 pathway
02

Mechanism of action

Pharmacological activation of the pathway generally occurs by upregulating Klotho expression or activity, which inhibits the PI3K/AKT signaling axis. This inhibition prevents the phosphorylation-dependent nuclear export of FOXO1, allowing it to remain in the nucleus and activate the transcription of antioxidant, anti-apoptotic, and longevity-promoting genes.

03

Biological functions

Longevity regulationOxidative stress resistancePhosphate homeostasisInsulin/IGF-1 signaling inhibitionApoptosis regulationCell cycle progressionGlucose metabolismAnti-inflammatory response
04

Disease associations

Chronic kidney diseaseCardiovascular diseaseCancerDiabetes mellitusNeurodegenerative diseaseAging-related disorders
05

Safety considerations

Hyperphosphatemia due to Klotho's role in mineral metabolismPotential disturbance of glucose homeostasis and gluconeogenesis by FOXO1 activationRisk of off-target apoptosis or cell cycle arrest in healthy tissues
06

Interacting drugs

SGLT2 inhibitors (e.g., Canagliflozin, Dapagliflozin)

6 more in the full profile.

07

Biomarkers

Serum soluble Klotho (s-Klotho)Urinary Klotho levelsSuperoxide dismutase 2 (SOD2/MnSOD) expressionFOXO1 phosphorylation status (p-FOXO1)Catalase levels

Beyond the preview

Go deeper on Klotho-Forkhead box protein O1 signaling pathway (KL-FOXO1 pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klotho-Forkhead box protein O1 signaling pathway (KL-FOXO1 pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call